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Heterocyclic aromatic amines (HAAs) are animal carcinogens and suspected human carcinogens which are formed in cooked foods at the low parts
per billion level. HAAs in cooked meats were purified by either immunoaffinity chromatography or solid phase tandem extraction, which allowed for
the simultaneous analysis of 11 HAAs by HPLC. The metabolism of two prominent HAAs, 2-amino-3,8-dimethylimidazol4,5-f]quinoxaline (MelQx)
and 2-amino-3-methylimidazo[4,5-flquinoline (IQ), was investigated in animal models and in vitro with human tissues to develop strategies for
human biomonitoring. MelQx and 10 are rapidly absorbed from the gastrointestinal tract of rodents and transformed into several detoxification products
which are excreted in urine and feces. Metabolites result from cytochrome P450-mediated ring oxidation at the C-5 position followed by conjugation
to sulfate or f-glucuronic acid. Other major metabolites include the phase 11 conjugates, N -glucuronide and N -sulfamate. A metastable N2-glu-
curonide conjugate of the genotoxic metabolite of /N-hydroxy-MelQx was also detected in urine and bile. The binding of both carcinogens to blood
proteins was low and suggests that human biomonitoring through protein adducts may be difficult. These metabolic pathways exist in nonhuman
primates and several of these pathways also occur in vitrowith human liver. The urinary excretion of MelQx in seven human subjects following con-
sumption of cooked beef or fish ranged between 2 and 22 ng in 12 hr when determined by negative ion chemical ionization GC-MS. After acid
hydrolysis of urine, the amount of MelQx increased 4- to 10-fold in 6 of the 7 subjects. These acid labile metabolites were identified as the N2-sulfa-
mate and N2-glucuronide following column chromatography and HPLC purification. Thus, amine sulfamation and N2-glucuronidation are important
routes of detoxification of MelOx in rodents, nonhuman primates, and humans. - Environ Health Perspect 102(Suppl 6):47-51 (1994)
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Introduction
More than a dozen heterocyclic aromatic
amines (HAAs) have been identified in
cooked foods at the low part per billion
level (1) and all HAAs tested so far are car-
cinogenic in rodent bioassays (2). One of
these food-borne mutagens, 2 amino-3-
methylimidazo[4,5-flquinoline (IQ), is
also a potent hepatocarcinogen in nonhu-
man primates (3). Metabolic studies with
human tissues show that humans activate
HAAs at appreciable levels. Activities for
some substrates are comparable to those
observed in rodents (4-8). Thus, despite
the occurrence of HAAs in only trace
amounts, their presence in many common
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foods suggests that human exposure can be
significant and that HAAs may be involved
in the etiology ofhuman cancers.
The risk evaluation ofgenotoxins such
as HAAs is based on quantitative estimates
of exposure and on the formation of toxi-
cologically active metabolites in target tis-
sues. In recent years, both DNA and
protein adducts have been used successfully
as biologic markers to measure human
exposure and to estimate the formation of
the genotoxic metabolites of a variety of
environmental and dietary carcinogens
(9,10). The most direct evidence of recent
exposure and genetic damage is through
the measurement of DNA adducts in cells
and their excretion products in urine;
whereas measurement of protein adducts
may provide an index oflong-term exposure
over the lifetime ofthe protein. Analysis of
urinary metabolites ofxenobiotics may also
provide important biologic data. For exam-
ple, human acetyltransferase and cytochrome
P4501A2 metabolic phenotype activity can
be determined by analysis of caffeine
metabolites in urine and may be used as
biomarkers ofcancer susceptibility (11,12).
The analysis of urinary metabolites of
genotoxins, such as HAAs, may also pro-
vide important information on the ability of
humans to metabolically activate or detox-
ify these procarcinogens and may aid in
risk evaluation. Our recent data on the
quantification of HAAs in cooked foods,
the metabolism of IQ and 2-amino-3,8-
dimethylimidazo[4,5-f]quinoxaline
(MeIQx) in experimental animals, and our
preliminary data on human metabolism are
presented in this article.
Methods
Quantification ofHAAs in
CookedFoods
HAAs were isolated from cooked meats
and fish by solid-phase tandem extraction
using an Extrelut-20 column in series with
a propylsulfonic acid silica cartridge and
quantified with multiple internal stan-
dards(13,14). HAAs were quantified by
HPLC employing a Hewlett-Packard
1090M system containing both a UV
diode array detector and a fluorimeter. A
Vydac 201HS52 narrow bore reverse-phase
column was used for increased sensitivity
and resolution.
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Metabolism Studies inAnimalModels
Metabolism studies were performed with
male Sprague-Dawley rats. MeIQx was
administered bygavage as its acetate salt. In
some instances, animals were pretreated with
a single ip injection ofAroclor 1254 in corn
oil 24 hr prior to dosing (15). Metabolites
were isolated from biologic fluids and refer-
ence standards were prepared either biosyn-
thetically using rat hepatocytes or through
chemical syntheses (16). Urine and bile
were obtained from nonhuman primates
undergoing carcinogen bioassays with IQ
and MeIQx (3) and metabolites were puri-
fied and spectroscopically characterized as
previously reported (17).
Metabolism Studies in Humans
Analysis ofMeIQx and its metabolites in
human urine was done by negative ion
chemical ionization gas chromatogra-
phy-mass spectrometry (NICI-GC-MS)
after derivatization with 3,5-bis(trifluo-
romethyl)benzyl bromide (18). Trideutero-
labeled (N-Cd3)-MeIQx was used as an
internal standard. Each of the seven sub-
jects consumed 1 lb (before cooking) of
panfried fish or beef. Urine collections were
made 0 to 12 hr postmeal. Aliquots of
urine were analyzed for unchanged MeIQx
before and after acid hydrolysis (1 N HCI
at 700C for 6 hr) which cleaves the N2-glu-
curonide and N2-sulfamate conjugates
with quantitative recovery of MeIQx (19).
The samples, both nonhydrolyzed and acid
hydrolyzed, underwent solvent partitioning
and immunoaffinity chromatography prior
to NICI-GC-MS analyses (Hewlett-
Packard 5987 GC-MS system and an HP-
1 capillary column) (20). MeIQx and the
deuterated internal standard were detected
and quantified by selective ion monitoring
ofthe ions at mz 438 and mz 441, respec-
tively (corresponding to the M-227 ions of
the [di(3,5-(bis-trifluoromethyl)benzyl]
derivatives). The N -sulfamate and the
N2-glucuronide were isolated from human
urine as described (15) except that solid
phase extraction steps with both C-18 and
aminopropyl resins were included after the
organic precipitation of urine. The urine
extract was dissolved in 30 ml 50 mM
ammonium acetate, pH 6.8, and then
applied to a Partisil (C-18) column. After
washing with this buffer, metabolites were
eluted in 50% methanol and dried. The
residue was dissolved in water, its pH
adjusted to 8.0 and then applied to a
propylamine cartridge. The eluent was
dried, redissolved in 1 ml of 50 mM
ammonium acetate (pH 6.8), diluted with
9 ml acetonitrile and applied to the propyl-
amine cartridge in normal phase mode.
The sulfamate was eluted with 30%
ammonium acetate buffer and 70% ace-
tonitrile and then the N2-glucuronide was
eluted with 50 mM ammonium acetate
containing 2% ammonium hydroxide
(vol/vol). This extraction procedure
enabled partial seqaration ofthe N2-sulfa-
mate from the N -glucuronide conjugate
(20), which was verified by HPLC (15)
and byNICI-GC-MS.
Results
The solid phase tandem extraction proce-
dure is highly selective for the purification
ofHAAs and enables quantification at levels
approaching 1 ppb. HAA content was
determined in several cooked foods with
this extraction procedure and the data is
presented in Table 1. The production of
these genotoxins in cooked foods varied
greatly and depended on the type ofmeat,
cooking temperature and manner ofprepar-
ation. High levels of HAAs were also
detected in cooking grill scrapings, which
are often used as a gravy base. A typical
chromatogram ofpurified HAAs in from
grill scrapings is shown in Figure 1.
MeIQx and IQmetabolism were inves-
tigated in animal models to develop strate-
gies for human biomonitoring. In the rat,
MeIQx metabolism and disposition were
Table 1. Heterocyclic amines in cooked meats and fish.
Sample identification MelQxa SE 4.8-DiMelQx SE PhlP SE AaC SE
Grilled meat 2 x 3 minb 0.8 ND 0.7 ND
Grilled meat 2 x 5 min 2.0 0.1 ND 3.2 1.7 ND
Grilled meat 2 x 7 min ND ND ND ND
Grill residue 29 3 4.2 0.2 144 38 76.5 5.6
Pan fried fish 2 x 3 minC 1.4 0.01 ND 1.7 0.7 ND
Pan fried fish 2 x 6 min 5 0.3 ND 23 7 4.6
Pan fried fish 2 x9 min 4.7 0.2 ND 14 2.8 8
Pan fried fish 2 x 12 min 3.7 0.2 ND 17 0.6 9
Barbecued turkey 2 x 2 minb ND ND 7 1.2 6.4 0.7
Barbecued turkey 2 x4 min 1.5 0.4 ND 50.6 6.3 103 11
Abbreviations: ND, not detectable (below 0.5 ng/g); SE, standard error. No SE are given for values below 1 ng/g.
"Values given in ng/g cooked meat or fish and are corrected for incomplete recovery during extraction. bSurface
temperature ofgrill orbarbecue measured using a thermocouple was 250°-270°C. CPantemperature was200°C (14).
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Figure 1. HPLC analysis of heterocyclic aromatic amines in grilled meat residue. Inset shows online UV spectra of
MelOx and PhIP along with reference standards.
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Figure 2. Structures of the 5 major metabolites of MelQx excreted in rat urine: N-(3-8-dimethylimdazo[4,5-
flquinoxalin-2-yl)sulfamic acid (NSOQ); N2-(B-1-glucosiduronyl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (N-
GI); N2-()-l-glucosiduronyl)-N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (HO-N-GI);
2-amino-5-(,-glucosiduronyloxy)-3,8-dimethylimidazo[4,5-f]quinoxaline (5-0-GI); 2-amino-3,8-dimethylimidazo[4,5-
fjquinoxaline-5-yl sulfate (5-OSO).
dependent upon dose and animal pretreat-
ment with PCB. At the 20 mg/kg treat-
ment approximately 50% of the dose was
excreted in urine within 24 hr while at the
lowest dose tested 20 to 25% ofthe dose
was recovered in urine and the remainder
recovered in feces (15). The 5 major metabo-
lites excreted in urine and bile are the sul-
fate and ,B-glucuronic acid conjugates of
the 5-hydroxy derivative of MeIQx, the
N2-glucuronide and the N2-sulfarnate
phase II conjugates, and the N2-glu-
curonide conjugate of the procarcinogenic
metabolite, N-hydroxy-MeIQx (Figure 2)
(15). At thehighest dose tested, N -sulfamate
formation was the major route ofdetoxifi-
cation and urinary elimination of MeIQx
in noninduced animals. However, other
metabolic pathways, such as 5-hydroxyla-
tion of MeIQx and N2-glucuronidation,
were more prominent both at lower doses
and in animals pretreated with PCB
(Figure 3). In animals treated with MeIQx
at 0.01 mg/kg, each of the above metabo-
lites accounted for 0.5 to 4% of the total
dose in urine whereas unmetabolized
MeIQx accounted for 0.5 to 2% of the
dose. Notably, the formation and excretion
of the metastable N2-glucuronide conju-
gate of N-hydroxy-MeIQx was relatively
more important at low-dose exposure.
Urine samples (8 hr collections) from
rats dosed with MeIQx (0.01 mg/kg) were
analyzed before (Figure 4) and after hydrol-
ysis, which resulted in cleavage of all the
characterized metabolites. MeIQx recovery
in urine after acid hydrolysis increased
from 2 to approximately 7% ofthe dose in
non-induced animals and from 0.5% to
nearly 6% of the dose in PCB pretreated
animals (n=4 animals). This increase in
MeIQx was commensurate to the amount
of cleaved sulfamate and N2-glucuronide.
The 5-hydroxy derivative of MeIQx and
the genotoxic metabolite, N-hydroxy-
MeIQx, the initial hydrolysis product of
the N-hydroxy-N2-glucuronide, are unsta-
ble under these acid hydrolysis conditions
and were not analyzed.
These metabolism pathways also occur
in the rodent for the structurally related
food mutagen IQ after high dose exposure;
however, the N -glucuronide conjugate of
N-hydroxy-IQ was not detected (21,22).
These pathways also have been detected in
nonhuman primates undergoing carcino-
gen bioassays with MeIQx (23) and IQ
(3,17). In the case of IQ, several other
metabolic routes were reported (17)
including N-demethylation and bacterial
mediated oxidation at the C-7 position of
the heterocyclic nucleus.
We sought to determine whether
humans detoxify MeIQx by phase II conju-
gation reactions, such as sulfamation and
N2-glucuronidation, and thus, analyzed
MeIQx in urine, both before and after acid
hydrolysis, from seven subjects who con-
sumed fried beef or fish (Figure 5). The
values of MeIQx recovered within 12 hr
ranged between 2 and 22 ng. Following
acid hydrolysis, the amounts ofMeIQx in
urine increased 4- to 10-fold in six of the
subjects, while there was little change in
the amount ofMeIQx in the urine of one
subject. The acid labile metabolites of two
subjects were purified by solid phase extrac-
tion with the aminopropyl cartridges, and
the N -sulfamate and the N2-glucuronide
phase II conjugates accounted for essen-
tially all of the acid labile material recov-
ered as MeIQx. This data was supported by
isolating urinary fractions by HPLC at
retention times corresponding to the
respective conjugates followed by
NICI-GC-MS analysis of MeIQx after
acid hydrolysis (15). Further work is being
carried out to confirm directly the identity
ofthe conjugates by mass spectrometry.
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Figure 3. Percent distribution of major urinary metabo-
lites of MelQx in rats as a function of dose and
cytochrome P450 induction with Aroclor 1254. (n=4
animals per group, *p<0.05)
20 .01
10,000I
N2GI
5L.\
_gEAl&'
HO-N2-1
AJ:i moa
5-C)SO- /A
.~~~~~~A 1 VW ww NM" mW FUIIL
20
Tlnm (min)
Figure 4. HPLC analysis of urinary metabolites from
rats given [2-4C]MelQx (37 mCi/mmole) at 0.01 mg/kg.
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Figure 5. MelQx content in human urine following
consumption of pan-fried beef or fish. Analyses were
made before and after acid hydrolysis.
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Discussion
To assess human exposure to HAAs, rapid
and reliable analytical methods are required
to quantitate these compounds in foods.
We demonstrated previously that immuno-
affinity chromatography rapidly isolates
HAAs from complex mixtures (24).
However, due to the high selectivity of
monoclonal antibodies, analysis and quan-
tification of HAAs are limited to the com-
pound against which the antibody is raised
(and possibly several structurally related
compounds). Consequently, a broad panel
ofantibodies is required for immunoaffinity
purification of the many structurally
diverse HAAs found in cooked foods.
Therefore, we developed a more general
analytic method that could be used to
detect a wide range of HAAs. With this
solid phase tandem extraction procedure, it
is possible to analyze simultaneously 11
HAAs formed in cooked foods at the low
parts per billion level by HPLC (13,14).
We have seen that grill scrapings, often
used as a gravy base, may contain high levels
of HAAs. This is in agreement with high
levels of mutagenicity reported in gravy
(25) and indications that the critical pre-
cursors of HAA formation are present in
the meat juice (26).
Protein dosimetry has been used to
monitor human exposure to several classes
ofcarcinogens (10). The rodent model is a
good surrogate for blood protein adduct
formation of several different carcinogens,
including the alylamine 4-aminobiphenyl,
where over 5% of a dose binds to hemoglo-
bin via an acid labile sulfinamide linkage.
This adduct is also formed in humans at
comparable levels and results from a series
of reactions between the hemoprotein and
the carcinogenic N-hydroxy metabolite
(10). However, the binding ofMeIQx to
hemoglobin in the rat is below 0.01% of
the dose and induction of cytochrome
P450 actually resulted in lower levels of
protein binding (15). Blood protein bind-
ing ofthe HAA analog, IQ, is also very low
in rodents (27) and in nonhuman primates
(17). Hemoglobin sulfinamide adducts of
IQ and MeIQx are formed in vitro using
enzymatically generated or synthetic N-
hydroxy derivatives (27) indicating that
these genotoxic metabolites are sufficiently
stable to penetrate the erythrocyte and
react with the hemoprotein. The absence of
this adduct in vivo suggests that very low
levels of the N-hydroxy metabolites are
excreted by the liver into the blood stream.
Thus, based on animal models, human
monitoring ofthese two mutagens by pro-
tein dosimetry may be difficult. In support
of this conclusion, a preliminary study
assaying for hemoglobin sulfinamide
adducts ofMeIQx in humans showed that
the adducts, ifpresent, were below levels of
detection using NICI-GC-MS (28). An
IQ sulfinamide-serum albumin adduct has
been detected in rodents (27) and this
linkage may be formed for many aromatic
and heterocyclic aromatic amines as well
(10). However, in the case of IQ and
MeIQx, the levels are low and protein
dosimetry with such an adduct may prove
difficult.
MeIQx is rapidly absorbed and exten-
sively metabolized in the rat to form five
principal metabolites which are excreted in
urine. Four ofthese metabolites are detoxi-
fication products, while the fifth is a
metastable N2-glucuronide conjugate of
the genotoxic metabolite N-hydroxy-
MeIQx (15). At the lowest dose ofMeIQx
2 administered (0.01 mg/kg), the N -sulfa-
mate and N2-glucuronide excreted in urine
accounted for approximately 25% of the
urinary excretion of MeIQx and its
metabolites (corresponding to approxi-
mately 5% of the total dose). This dose is
onlyseveral hundred-fold greater than daily
human exposure to MeIQx (1). Sulfamate
2 formation and N -glucuronidation are two
of the major routes of MeIQx and IQ
detoxification. In rodent (15,19,21,22,29),
nonhuman primate (23) and human liver
also appear to catalyze these reactions in vitro
[(30); R Turesky, unpublished observa-
tions].
In preliminary experiments with humans,
six of seven subjects excreted MeIQx
metabolites as acid labile phase II conju-
gates, while there was no evidence ofacid
labile metabolite formation in the remain-
ing subject. The 4- to 10-fold increase in
MeIQx content in human urine following
acidhydrolysis is comparable to the increase
of MeIQx detected in urine of rodents
given MeIQx at 0.01mg/kg following acid
treatment. We isolated these acid labile
metabolites from two human subjects, and
nearly all ofthe acid labile material recovered
as MeIQx is attributed to the N2-sulfamate
2 and the N -glucuronide conjugates. With
the development of internal standards for
these metabolites, a better estimation of
their relative contribution to MeIQx
metabolism and detoxification can be
determined. Rodents, nonhuman primates,
and humans appear to have at least two
common metabolic routes of MeIQx
detoxification.
Recently, the thermostable phenolsulfo-
transferase (TS PST) in human liver was
shown to catalyze the sulfamation of 2-
naphthylamine (31). This sulfotransferase
also appears to be responsible for the meta-
bolic activation ofseveral N-hydroxy aro-
matic and heterocyclic aromatic amines to
reactive DNA binding species (32,34).
Thus, sulfotransferase has a dual role in
HAA metabolism and is involved both in
metabolic activation as well as detoxifica-
tion. TS PST activity varies greatly in indi-
viduals and exhibits a genetic poly-
morphism (31,33). Consequently, studies
are required to assess the role of human
sulfotransferases in HAA carcinogenesis.
Human liver metabolically activates
MeIQx and other HAAs through
cytochrome P450-mediated N-oxidation
and subsequent esterification reactions to
produce the ultimate carcinogenic metabo-
lites (4-7,32,34). Analytic developments
are underway to quantify the N-hydroxy-
N2-glucuronide conjugate ofMeIQx, an
index of metabolic activation of this pro-
carcinogen, in human urine. This method
will be used to evaluate better both the
metabolic activation and detoxification of
MeIQx and, therefore, to assess health risk
ofthis dietary mutagen.
NoteAddedinProof
We recently have identified a glucuronide
conjugate of MeIQx in urine and bile of
nonhuman primates undergoing carcino-
gen bioassays (23). IH-NMR and FAB-MS
spectroscopy support the structure as a N -
glucuronide (Turesky RJ, Welti DH, Fay
LB, Snyderwine EG, unpublished observa-
tions). The relative contribution of this
metabolite, which has very similar chro-
matographic properties to MeIQx-N2-glu-
curonide, in human detoxification of
MeIQx remains to be established.
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